The potential long-term comparative effectiveness of larotrectinib versus regorafenib or trifluridine/tipiracil for treatment of metastatic TRK fusion colorectal cancer

被引：0
|
作者：
Suh, Kangho
Carlson, Josh John
Xia, Fang
Williamson, Todd E.
Sullivan, Sean D.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 04期
关键词：
D O I：
10.1200/JCO.2022.40.4_suppl.041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
41
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Sequential Treatment With Trifluridine/Tipiracil and Regorafenib in Refractory Metastatic Colorectal Cancer Patients: An AGEO Prospective "Real-World Study"
    Coutzac, Clelia
    Trouilloud, Isabelle
    Pascal, Artru
    Henriques, Julie
    Masson, Therese
    Doat, Solene
    Bouche, Olivier
    Coriat, Romain
    Saint, Angelique
    Moulin, Valerie
    Vernerey, Dewi
    Gallois, Claire
    De La Fouchardiere, Christelle
    Tougeron, David
    Taieb, Julien
    CLINICAL COLORECTAL CANCER, 2022, 21 (02) : 132 - 140
  • [42] Comparative effectiveness of larotrectinib versus entrectinib for the treatment of metastatic NTRK gene fusion cancers
    Suh, Kangho
    Carlson, Josh J.
    Xia, Fang
    Williamson, Todd
    Sullivan, Sean D.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2022, 11 (14) : 1011 - 1019
  • [43] Effectiveness and safety of trifluridine/tipiracil in patients with metastatic colorectal cancer in clinical practice in Poland
    Radecka, B.
    Gelej, M.
    Streb, J.
    Siedlaczek, A.
    Kryka, K.
    Tokajuk, P.
    Winsko-Szczesnowicz, K.
    Czernek, U.
    Sobczak, M.
    Malik, M.
    Bodnar, L.
    Foszczynska-Kloda, M.
    Hetman, K.
    Skiewicz, M. Welnicka-Ja
    Wierzbicka, K.
    Orlikowska, M.
    Becht, R.
    Deptala, A.
    Itrych, B.
    Kania-Zembaczynska, B.
    ANNALS OF ONCOLOGY, 2020, 31 : S108 - S108
  • [44] ECONOMIC EVALUATION OF TRIFLURIDINE AND TIPIRACIL HYDROCHLORIDE IN THE TREATMENT OF METASTATIC COLORECTAL CANCER IN GREECE
    Gourzoulidis, G.
    Kourlaba, G.
    Petrakis, D.
    Souglakos, I
    Pentheroudakis, G.
    Maniadakis, N.
    VALUE IN HEALTH, 2017, 20 (09) : A434 - A434
  • [45] Impact of tumour growth rate during preceding treatment on tumour response to regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer
    Masuishi, Toshiki
    Taniguchi, Hiroya
    Kawakami, Takeshi
    Kawamoto, Yasuyuki
    Kadowaki, Shigenori
    Onozawa, Yusuke
    Muranaka, Tetsuhito
    Tajika, Masahiro
    Yasui, Hirofumi
    Nakatsumi, Hiroshi
    Yuki, Satoshi
    Muro, Kei
    Omae, Katsuhiro
    Komatsu, Yoshito
    Yamazaki, Kentaro
    ESMO OPEN, 2019, 4 (06)
  • [46] Economic evaluation of trifluridine and tipiracil hydrochloride in the treatment of metastatic colorectal cancer in Greece
    Gourzoulidis, George
    Maniadakis, Nikos
    Petrakis, Dimitrios
    Souglakos, John
    Pentheroudakis, George
    Kourlaba, Georgia
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2019, 8 (03) : 133 - 142
  • [47] Long-term efficacy and safety of larotrectinib in an integrated dataset of patients with TRK fusion cancer.
    Hong, David S.
    Shen, Lin
    van Tilburg, Cornelis Martinus
    Tan, Daniel Shao-Weng
    Kummar, Shivaani
    Lin, Jessica Jiyeong
    Doz, Francois P.
    McDermott, Raymond S.
    Albert, Catherine M.
    Berlin, Jordan
    Bielack, Stefan S.
    Lassen, Ulrik Niels
    Tahara, Makoto
    Norenberg, Ricarda
    Shurshalina, Anna
    Fellous, Marc Mardoche
    Nogai, Hendrik
    Xu, Rui-hua
    Laetsch, Theodore Willis
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Daisuke Kotani
    Yasutoshi Kuboki
    Satoshi Horasawa
    Asumi Kaneko
    Yoshiaki Nakamura
    Akihito Kawazoe
    Hideaki Bando
    Hiroya Taniguchi
    Kohei Shitara
    Takashi Kojima
    Akihito Tsuji
    Takayuki Yoshino
    BMC Cancer, 19
  • [49] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
    Li, Rong-Rong
    Zhou, Hui-Jun
    Zeng, De-Yu
    Jiang, Shao-Feng
    Liu, Wu
    Fruehling, Petter
    Liu, Zhen-Yang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 612 - 629
  • [50] Predictive factors for early mortality after initiation of regorafenib or trifluridine/tipiracil in refractory metastatic colorectal cancer.
    Masuishi, Toshiki
    Moriwaki, Toshikazu
    Fukuoka, Shota
    Takashima, Atsuo
    Kumekawa, Yosuke
    Kajiwara, Takeshi
    Yamazaki, Kentaro
    Esaki, Taito
    Makiyama, Akitaka
    Denda, Tadamichi
    Satake, Hironaga
    Suto, Takeshi
    Sugimoto, Naotoshi
    Katsumata, Kenji
    Ishikawa, Toshiaki
    Kashiwada, Tomomi
    Oki, Eiji
    Komatsu, Yoshito
    Yoshimura, Kenichi
    Shimada, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345